Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
|Articles|March 1, 2013
I Holland Limited Spring Show Guide
Advertisement
More than six decades of research, development and investment has established I Holland as a leading global supplier of quality punches and dies to tablet manufacturers.
I Holland is wholly committed to the provision of a comprehensive pre and after–sales support service, to ensure that each and every tablet compression tooling requirement receives focused and individual attention. Customers benefit from enhanced tooling performance through our unwavering dedication to the understanding of tabletting science.
E-mail:
Website:
Shows attending:
- INTERPHEX - booth 3164
Advertisement
Related to this article
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF in Tarrytown, spoke with PharmTech at AAPS PharmSci 360 about formulation and characterization challenges for amorphous solid dispersions.
FDA draft guidance on individualized genome editing lets BLAs add patient-specific variants without new trials, shifting evidence to CMC assay data.
Bill Williams, AAPS, compares KinetiSol and spray drying for amorphous solid dispersions, covering 75% drug loading, pill burden, weakly basic drug release, and process limits.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
From URS to Acceptance Evidence: Defining and Testing Interfaces in Pen Injector Assembly
2
AAPS PharmSci 360 2026: IND-Enabling Studies vs Animal Data
3
AAPS PharmSci 360 2026: Roller-Compacted Formulations
4
Formulation Risk Needs One Accountable Owner: AAPS PharmSci 360 2026
5